ImmunoPrecise Antibodies (IPA) announced that Kristin Taylor has resigned from her position as Chief Financial Officer effective January 16, 2025. Ms. Taylor will continue to serve in the role of CFO until January 16, 2025, and will remain available to the company on a consulting basis after that time. IPA has initiated a CFO succession process and will provide updates as appropriate.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IPA:
- ImmunoPrecise Antibodies CFO Resignation and Succession
- ImmunoPrecise Antibodies Shows Market Confidence
- ImmunoPrecise Antibodies exhibits market confidence with insider transactions
- ImmunoPrecise Antibodies to Showcase at Microcap Conference
- ImmunoPrecise Antibodies price target lowered to $7 from $9 at H.C. Wainwright